Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-24Clinical Trial Update: Device-guided Breathing Exercises on Blood Pressure in Diabetic Patients [Phase 3]
Phase 3 trial evaluating device-guided breathing exercises to reduce blood pressure in adults with hypertension and type 2 diabetes has comp…
-
CLINICAL_TRIALS trial_result · 2012-10-24Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus [Phase 3]
Phase 3 study comparing once-weekly exenatide injections to once-daily insulin in type 2 diabetes has completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion [Phase 4]
Phase 4 trial investigating nateglinide's effect on postprandial glucose by restoring early-phase insulin secretion in type 2 diabetes; resu…
-
CLINICAL_TRIALS research · 2012-10-19Clinical Trial Update: DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients
A clinical trial investigates how DPP-4 inhibitors may influence cancer-related mechanisms in patients with Type 2 Diabetes Mellitus.
-
FDA approval · 2012-10-18FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Januvia (sitagliptin) from Merck Sharp & Dohme LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-10-18FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUMET (sitagliptin and metformin hydrochloride) submitted by Merck Sharp & Dohme LLC to up…
-
FDA approval · 2012-10-18FDA Approved: JANUMET XR — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUMET XR (sitagliptin and metformin hydrochloride) to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Using Conversation Maps to Reinforce Self-Care [NA]
A completed clinical trial evaluating the use of Conversation Maps to reinforce self-care in adults with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756 [Phase 4]
Phase 4 extension study comparing two initial dosage split regimens of biphasic insulin aspart 30 given twice daily in adults with type 2 di…
-
CLINICAL_TRIALS trial_result · 2012-10-16Clinical Trial Update: The Effects of Soy Isoflavones to Improve the Metabolism of Glucose and Lipids [NA]
This clinical trial evaluated whether soy isoflavones improve glucose and lipid metabolism in adults with Type 2 Diabetes Mellitus; the stud…
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes [Phase 3]
Phase 3 study evaluating BRL 49653C for type 2 diabetes mellitus has completed, assessing its efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Regulation of Tissue Lipolysis by Insulin in Type 2 Diabetes
A completed clinical trial from Maastricht University Medical Center investigated how insulin regulates tissue lipolysis in people with Type…
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes
A Takeda-sponsored cohort study evaluating pioglitazone in patients with type 2 diabetes for bladder cancer risk; the trial is completed and…
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus [Phase 2]
Phase II study evaluating oral ONO-5129 in Type 2 diabetes mellitus; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: Vitamin D Inadequacy is Associated With Incidence of Type 2 Diabetes
A completed study reports that inadequate vitamin D status is associated with a higher incidence of Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea [Phase 4]
Phase 4 trial evaluating adding sitagliptin or pioglitazone to metformin and sulfonylurea in type 2 diabetes mellitus with insufficient glyc…
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005) [Phase 1]
Phase 1 single-dose study of MK-1006 in Japanese patients with Type 2 Diabetes Mellitus, completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-08Clinical Trial Update: Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262) [Phase 3]
Phase 3 study comparing sitagliptin with a sulfonylurea for type 2 diabetes during Ramadan fasting has completed and results were posted in …
-
FDA approval · 2012-10-05FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Metformin Hydrochloride (Ascend Laboratories, LLC) under an ANDA.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension Trial [Phase 3]
This update reports results from the EASIE extension trial, a Phase 3 study evaluating insulin glargine in combination with sitagliptin for …
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Activity and Metformin Intervention in Obese Adolescents [Phase 4]
Phase 4 clinical trial evaluating metformin intervention in obese adolescents (including those with Type 2 diabetes) has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Physical and Chemical Study of Atherosclerosis Mechanisms [Phase 4]
Phase 4 trial investigating physical and chemical mechanisms of atherosclerosis in patients with myocardial infarction and coronary artery d…
-
CLINICAL_TRIALS trial_result · 2012-10-03Clinical Trial Update: A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017) [Phase 2]
A Phase 2 clinical trial evaluating MK-0941 in patients with type 2 diabetes mellitus inadequately controlled on metformin was completed, wi…
-
CLINICAL_TRIALS trial_result · 2012-10-03Clinical Trial Update: MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011). [Phase 1]
This ClinicalTrials.gov entry reports the completion of a Phase 1 multiple-dose study of MK-0941 in Japanese patients with Type 2 diabetes m…
-
CLINICAL_TRIALS research · 2012-10-03Clinical Trial Update: Health2006 - an Observational Study of Cardiovascular Disease, Diabetes, Asthma and Allergy
Health2006 is an observational study on cardiovascular disease, type 2 diabetes, asthma, hypersensitivity, and osteoporosis that has complet…